651 related articles for article (PubMed ID: 12813001)
1. Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor.
Klegeris A; Bissonnette CJ; McGeer PL
Br J Pharmacol; 2003 Jun; 139(4):775-86. PubMed ID: 12813001
[TBL] [Abstract][Full Text] [Related]
2. Expression and function of cannabinoid receptors CB1 and CB2 and their cognate cannabinoid ligands in murine embryonic stem cells.
Jiang S; Fu Y; Williams J; Wood J; Pandarinathan L; Avraham S; Makriyannis A; Avraham S; Avraham HK
PLoS One; 2007 Jul; 2(7):e641. PubMed ID: 17653268
[TBL] [Abstract][Full Text] [Related]
3. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats.
Sagar DR; Kelly S; Millns PJ; O'Shaughnessey CT; Kendall DA; Chapman V
Eur J Neurosci; 2005 Jul; 22(2):371-9. PubMed ID: 16045490
[TBL] [Abstract][Full Text] [Related]
5. Virodhamine and CP55,940 modulate cAMP production and IL-8 release in human bronchial epithelial cells.
Gkoumassi E; Dekkers BG; Dröge MJ; Elzinga CR; Schmidt M; Meurs H; Zaagsma J; Nelemans SA
Br J Pharmacol; 2007 Aug; 151(7):1041-8. PubMed ID: 17558435
[TBL] [Abstract][Full Text] [Related]
6. CB2 cannabinoid receptors promote mouse neural stem cell proliferation.
Molina-Holgado F; Rubio-Araiz A; García-Ovejero D; Williams RJ; Moore JD; Arévalo-Martín A; Gómez-Torres O; Molina-Holgado E
Eur J Neurosci; 2007 Feb; 25(3):629-34. PubMed ID: 17328768
[TBL] [Abstract][Full Text] [Related]
7. Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes.
Sheng WS; Hu S; Min X; Cabral GA; Lokensgard JR; Peterson PK
Glia; 2005 Jan; 49(2):211-9. PubMed ID: 15390091
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoids and the human uterus during pregnancy.
Dennedy MC; Friel AM; Houlihan DD; Broderick VM; Smith T; Morrison JJ
Am J Obstet Gynecol; 2004 Jan; 190(1):2-9; discussion 3A. PubMed ID: 14749627
[TBL] [Abstract][Full Text] [Related]
9. Role of cannabinoid receptors in inhibiting macrophage costimulatory activity.
Chuchawankul S; Shima M; Buckley NE; Hartmann CB; McCoy KL
Int Immunopharmacol; 2004 Feb; 4(2):265-78. PubMed ID: 14996418
[TBL] [Abstract][Full Text] [Related]
10. Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 in endotoxemic mice.
Smith SR; Terminelli C; Denhardt G
J Pharmacol Exp Ther; 2000 Apr; 293(1):136-50. PubMed ID: 10734163
[TBL] [Abstract][Full Text] [Related]
11. Methods evaluating cannabinoid and endocannabinoid effects on gastrointestinal functions.
Darmani NA
Methods Mol Med; 2006; 123():169-89. PubMed ID: 16506408
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid receptor-mediated regulation of intracellular calcium by delta(9)-tetrahydrocannabinol in resting T cells.
Rao GK; Zhang W; Kaminski NE
J Leukoc Biol; 2004 May; 75(5):884-92. PubMed ID: 14966196
[TBL] [Abstract][Full Text] [Related]
13. Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice.
Vigolo A; Ossato A; Trapella C; Vincenzi F; Rimondo C; Seri C; Varani K; Serpelloni G; Marti M
Neuropharmacology; 2015 Aug; 95():68-82. PubMed ID: 25769232
[TBL] [Abstract][Full Text] [Related]
14. THC Prevents MDMA Neurotoxicity in Mice.
Touriño C; Zimmer A; Valverde O
PLoS One; 2010 Feb; 5(2):e9143. PubMed ID: 20174577
[TBL] [Abstract][Full Text] [Related]
15. Expression and function of endocannabinoid receptors in the human adrenal cortex.
Ziegler CG; Mohn C; Lamounier-Zepter V; Rettori V; Bornstein SR; Krug AW; Ehrhart-Bornstein M
Horm Metab Res; 2010 Feb; 42(2):88-92. PubMed ID: 19862666
[TBL] [Abstract][Full Text] [Related]
16. Decrease in efficacy and potency of nonsteroidal anti-inflammatory drugs by chronic delta(9)-tetrahydrocannabinol administration.
Anikwue R; Huffman JW; Martin ZL; Welch SP
J Pharmacol Exp Ther; 2002 Oct; 303(1):340-6. PubMed ID: 12235269
[TBL] [Abstract][Full Text] [Related]
17. Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors.
Nader J; Rapino C; Gennequin B; Chavant F; Francheteau M; Makriyannis A; Duranti A; Maccarrone M; Solinas M; Thiriet N
Neuropharmacology; 2014 Dec; 87():214-21. PubMed ID: 24709540
[TBL] [Abstract][Full Text] [Related]
18. The THC-induced suppression of Th1 polarization in response to Legionella pneumophila infection is not mediated by increases in corticosterone and PGE2.
Newton CA; Lu T; Nazian SJ; Perkins I; Friedman H; Klein TW
J Leukoc Biol; 2004 Oct; 76(4):854-61. PubMed ID: 15258190
[TBL] [Abstract][Full Text] [Related]
19. Contrasting protective effects of cannabinoids against oxidative stress and amyloid-β evoked neurotoxicity in vitro.
Harvey BS; Ohlsson KS; Mååg JL; Musgrave IF; Smid SD
Neurotoxicology; 2012 Jan; 33(1):138-46. PubMed ID: 22233683
[TBL] [Abstract][Full Text] [Related]
20. The cannabinoid delta-9-tetrahydrocannabinol mediates inhibition of macrophage chemotaxis to RANTES/CCL5: linkage to the CB2 receptor.
Raborn ES; Marciano-Cabral F; Buckley NE; Martin BR; Cabral GA
J Neuroimmune Pharmacol; 2008 Jun; 3(2):117-29. PubMed ID: 18247131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
